Stereotaxis, Inc.
StreetZero Signal 67
About Stereotaxis, Inc.
Stereotaxis, Inc. is a public company headquartered in St. Louis, Missouri, that develops robotic systems for minimally invasive endovascular interventions, primarily in cardiac procedures. The company manufactures medical equipment and has treated over 150,000 patients globally across the US, Europe, Asia, and other regions. It operates a B2B business model and is listed on NYSE under STXS. Founded in 1990, it maintains a website at www.stereotaxis.com and LinkedIn presence with over 13,000 followers.
LATEST FUNDINGPrivate Placement
$12.0M
Announced 2026-11-19
TOTAL RAISED$166.5M
IN THE NEWS
- ๐ Stereotaxis
- ๐ Stereotaxis - 2026 Company Profile, Team, Funding, Competitors & Financials - Tracxn
- ๐ Stereotaxis - 2026 Funding Rounds & List of Investors - Tracxn
- ๐ St. Louis Business Journal
- ๐ Stereotaxis Secures $12.5M Strategic Investment for Robotics Commercialization | STXS Stock News
EMPLOYEESโ
FOUNDED1990
HQSt Louis, Missouri, United States
Industry
Other Health Care
Tags
B2BMedical EquipmentRoboticsPublic Company
Investors
Key highlights
- Stereotaxis has raised $12 million via private placement with investors not disclosed.
- The company has completed 11 funding rounds totaling $166.5 million including multiple post-IPO equity rounds.
- Its robotic systems have been used in over 150,000 patient procedures worldwide.
- Recent financing includes a $12.5 million registered direct offering to support commercialization and R&D.
- Headquartered in St. Louis, the public company focuses on minimally invasive endovascular surgical robotics.
Ask StreetZero about Stereotaxis, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account